These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11006009)

  • 1. Vigorous peripheral blood cytotoxic T cell response during the acute phase of hepatitis C virus infection.
    Cucchiarini M; Kammer AR; Grabscheid B; Diepolder HM; Gerlach TJ; Grüner N; Santantonio T; Reichen J; Pape GR; Cerny A
    Cell Immunol; 2000 Aug; 203(2):111-23. PubMed ID: 11006009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals.
    Vertuani S; Bazzaro M; Gualandi G; Micheletti F; Marastoni M; Fortini C; Canella A; Marino M; Tomatis R; Traniello S; Gavioli R
    Eur J Immunol; 2002 Jan; 32(1):144-54. PubMed ID: 11754355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionally distinct helper T-cell epitopes of HCV and their role in modulation of NS3-specific, CD8+/tetramer positive CTL.
    Zhu F; Eckels DD
    Hum Immunol; 2002 Sep; 63(9):710-8. PubMed ID: 12175725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between viral fitness and immune escape within the hepatitis C virus protease.
    Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
    Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DCs pulsed with novel HLA-A2-restricted CTL epitopes against hepatitis C virus induced a broadly reactive anti-HCV-specific T lymphocyte response.
    Guo Z; Zhang H; Rao H; Jiang D; Cong X; Feng B; Wang J; Wei L; Chen H
    PLoS One; 2012; 7(6):e38390. PubMed ID: 22701633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules.
    Battegay M; Fikes J; Di Bisceglie AM; Wentworth PA; Sette A; Celis E; Ching WM; Grakoui A; Rice CM; Kurokohchi K
    J Virol; 1995 Apr; 69(4):2462-70. PubMed ID: 7884894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection.
    Koziel MJ; Walker BD
    Springer Semin Immunopathol; 1997; 19(1):69-83. PubMed ID: 9266632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region.
    Kurokohchi K; Akatsuka T; Pendleton CD; Takamizawa A; Nishioka M; Battegay M; Feinstone SM; Berzofsky JA
    J Virol; 1996 Jan; 70(1):232-40. PubMed ID: 8523531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
    Cerny A; McHutchison JG; Pasquinelli C; Brown ME; Brothers MA; Grabscheid B; Fowler P; Houghton M; Chisari FV
    J Clin Invest; 1995 Feb; 95(2):521-30. PubMed ID: 7860734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
    Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
    J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients.
    Rehermann B; Chang KM; McHutchinson J; Kokka R; Houghton M; Rice CM; Chisari FV
    J Virol; 1996 Oct; 70(10):7092-102. PubMed ID: 8794355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cytotoxic T-lymphocyte responses to hepatitis C virus core protein in uninfected and infected individuals.
    Jackson M; Smith B; Bevitt DJ; Steward M; Toms GL; Bassendine MF; Diamond AG
    J Med Virol; 1999 Jul; 58(3):239-46. PubMed ID: 10447419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection.
    Wong DK; Dudley DD; Afdhal NH; Dienstag J; Rice CM; Wang L; Houghton M; Walker BD; Koziel MJ
    J Immunol; 1998 Feb; 160(3):1479-88. PubMed ID: 9570570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.
    Koziel MJ; Dudley D; Afdhal N; Choo QL; Houghton M; Ralston R; Walker BD
    J Virol; 1993 Dec; 67(12):7522-32. PubMed ID: 7693974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects co-infected with hepatitis C virus and HIV-1.
    Troesch M; Jalbert E; Canobio S; Boulassel MR; Routy JP; Bernard NF; Bruneau J; Lapointe N; Boucher M; Soudeyns H
    AIDS; 2005 May; 19(8):775-84. PubMed ID: 15867491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary and memory T cell responses induced by hepatitis C virus multiepitope long peptides.
    Fournillier A; Dupeyrot P; Martin P; Parroche P; Pajot A; Chatel L; Fatmi A; Gerossier E; Bain C; Lone YC; Trépo C; Inchauspé G
    Vaccine; 2006 Apr; 24(16):3153-64. PubMed ID: 16481078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral-blood mononuclear cell responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C.
    Schupper H; Hayashi P; Scheffel J; Aceituno S; Paglieroni T; Holland PV; Zeldis JB
    Hepatology; 1993 Nov; 18(5):1055-60. PubMed ID: 7693570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C Virus-Specific T Cell Receptor mRNA-Engineered Human T Cells: Impact of Antigen Specificity on Functional Properties.
    Balasiddaiah A; Davanian H; Aleman S; Pasetto A; Frelin L; Sällberg M; Lohmann V; Koh S; Bertoletti A; Chen M
    J Virol; 2017 May; 91(9):. PubMed ID: 28228595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection.
    Diepolder HM; Zachoval R; Hoffmann RM; Wierenga EA; Santantonio T; Jung MC; Eichenlaub D; Pape GR
    Lancet; 1995 Oct; 346(8981):1006-7. PubMed ID: 7475549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus.
    Chang KM; Rehermann B; McHutchison JG; Pasquinelli C; Southwood S; Sette A; Chisari FV
    J Clin Invest; 1997 Nov; 100(9):2376-85. PubMed ID: 9410918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.